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Sirtuins, class III histone deacetylases, are involved in the regulation of tissue repair 
processes and brain functions after a stroke. The ability of some isoforms of sirtuins to circulate 
between the nucleus and cytoplasm may have various pathophysiological effects on the cells.  In 
present work, we focused on the role of non-mitochondrial sirtuins SIRT1, SIRT2, and SIRT6 in 
the restoration of brain cells following ischemic stroke. Here, using a photothrombotic stroke (PTS) 
model in mice, we studied whether local stroke affects the level and intracellular localization of 
SIRT1, SIRT2, and SIRT6 in neurons and astrocytes of the intact cerebral cortex adjacent to the 
ischemic ipsilateral hemisphere and in the analogous region of the contralateral hemisphere at 
different time points during the recovery period after a stroke. We evaluated the co-localization of 
sirtuins with growth-associated protein-43 (GAP-43), the presynaptic marker synaptophysin (SYN) 
and acetylated α-tubulin (Ac-α-Tub), that are associated with brain plasticity and are known to be 
involved in brain repair after a stroke. The results show that during the recovery period, an increase 
in SIRT1 and SIRT2 levels occurred. The increase of SIRT1 level was associated with an increase 
in synaptic plasticity proteins, whereas the increase of SIRT2 level was associated with an 
acetylated of α-tubulin, that can reduce the mobility of neurites. SIRT6 co-localized with GAP-43, 
but not with SYN. Moreover, we showed that SIRT1, SIRT2, and SIRT6 are not involved in the 
PTS-induced apoptosis of penumbra cells. Taken together, our results suggest that sirtuins functions 
differ depending on cell type, intracellular localization, specificity of sirtuins isoforms to different 
substrates and nature of post-translational modifications of enzymes. 
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Sirtuins belong to III histone deacetylases. The activity of sirtuins requires nicotinamide 
adenine dinucleotide (NAD +), which makes these enzymes sensitive to metabolic and redox 
changes (Khoury et al., 2018). Unlike other deacetylases that hydrolyze acetyl-lysine residues, 
sirtuins deacetylate lysine residues and hydrolyze NAD. Sirtuins are named after protein Sir2, 
which modulates the lifespan of Saccharomyces cerevisiae (Kaeberlein et al., 1999). Seven sirtuins, 
SIRT 1-7, have been identified in mammals. SIRT1 and SIRT6 are mainly localized in the nuclei of 
cells, SIRT7, in the nucleoli, SIRT3, SIRT4 and SIRT5 are mitochondrial proteins, and SIRT2 is in 
the cytoplasm (Michishita et al., 2005). Sirtuins deacetylate various substrates, such as transcription 
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factors, cell metabolism enzymes, and histones. They are involved in the regulation of many 
biological processes, including metabolism, cell growth, apoptosis and autophagy, as well as in the 
genetic control of aging (Ham and Raju, 2017). 
Although evidence is accumulating in support of the neuroprotective role of SIRTs in 
ischemic stroke (Khoury et al., 2018; Conti et al., 2017), the function of the different sirtuin 
isoforms of sirtuins needs further investigation. The ability of some sirtuin isoforms of sirtuins to 
circulate between the nucleus and cytoplasm with different pathophysiological consequences for the 
cell requires a more detailed study of the cellular redistribution of sirtuins. In present study, we 
focused on the role of non-mitochondrial sirtuins SIRT1, SIRT2, and SIRT6 in the restoration of 
brain cells during the recovery period following ischemic stroke. Unlike the earlier stages of a 
stroke, the recovery period is poorly understood. Using a photothrombotic stroke model in mice, we 
studied whether local stroke affects the level and intracellular localization of SIRT1, SIRT2, and 
SIRT6 in neurons and astrocytes of the intact cerebral cortex adjacent to the infarct border 
(ischemic ipsilateral hemisphere) and in the analogous region of the contralateral hemisphere at the 
recovery period after a stroke. It is known that these adjacent brain regions are involved in the 
restoration of brain structure and functions after damage (Johansen-Berg et al, 2002; Seitz et al., 
1998). To identify the molecular targets of different sitruin isoforms, we evaluated their co-
localization with growth-associated protein-43 (GAP-43), the presynaptic marker synaptophysin 
(SYN) and acetylated α-tubulin (Ac-α-Tub), that are associated with brain plasticity and are known 
to be involved in brain repair after a stroke (Carmichael ST, 2005; Fletcher TL et al., 1991; Ng and 
Tang, 2015). 
The results show that during the recovery period, an increase in SIRT1 and SIRT2 is 
observed, but with opposite functional consequences. The increase of SIRT1 level was associated 
with an increase in the expression of markers of synaptogenesis and neurite growth, whereas the 
increase of SIRT2 level was associated with an acetylation of α-tubulin, that can reduce the 
mobility of neurites. SIRT6 co-localized with GAP-43, but not with SYN. SIRT1, SIRT2, and 
SIRT6 did not participate in the apoptosis of penumbra cells after photothrombotic stroke (PTS) in 
mice, despite the elevated levels of the cytoplasmic form of SIRT1. 
 




Polyvinylidene difluoride (PVDF) membranes, blocking buffer (TBS 1% Casein Blocker), 
and Сlarity Western ECL Substrate were purchased from Bio-Rad (Moscow, Russia). All other 





Adult (14-15week-old) male CD- 1 outbred mice (20-25 g), kept in groups of 4-5 mice with 
free access to food and water at 12 light/12 dark cycle, were used for the photothrombotic infarction 
of the cerebral cortex (in vivo model of ischemic stroke). The animal holding room was maintained 
at 22–25 °C, and an air exchange rate of 18 changes per hour. Anesthesia was caused by 
intraperitoneal injection of chloral hydrate (23100, Sigma) dissolved in 0.9% NaCl at a dose of 300 
mg/kg body weight in a volume of 0.25 ml. Body temperature was monitored by a rectal 
thermometer and maintained within 37 ± 0.5 °C using an electric mat. All procedures were 
performed in compliance with the ARRIVE guidelines for animal research and EU Directive 
2010/63/EU for animal experiments and local legislation for ethics of experiments on animals. The 
animal protocols used in this work were evaluated and approved by the Committee of Animal Care 
and Use of the Southern Federal University (Approval No. 08/2016). Randomization based on a 
single sequence of random assignments, known as simple randomization, was used to allocate 




2.1 Ischemic stroke model 
 
Local unilateral photothrombotic stroke (PTS) of the cerebral cortex was used in the study 
as a reproducible experimental model of ischemic stroke (Watson et al., 1985; Lee et al., 2006).   In 
PTS, local laser irradiation induces photoexcitation of the injected photosensitizing dye Rose 
Bengal (RB) causing damage to no more than 20% of brain tissue. This is the maximal volume of 
tissue damage that a human stroke patient can survive. In addition, PTS has several advantages, 
such as low invasiveness, high animal survival; high reproducibility of the same localization and 
degree of damage; long-term sensorimotor deficiency, allowing the use of this model in the study of 
the long-term effects of stroke (Watson et al., 1985; Lee et al., 2007).  The PTS procedure has been 
previously described (Demyanenko et al., 2018) Briefly, anesthesia was induced by i.p. injection of 
chloral hydrate (300 mg/kg). After the longitudinal incision of the skull skin, the periosteum was 
removed. A solution of the Rose Bengal photosensitizer (R4507) at the concentration of 15 mg/mL 
was introduced intraperitoneally at a dose of 10 µg/g of the animal weight. The hydrophilic 
photosensitizer Rose Bengal does not cross the blood-brain barrier and does not penetrate the cells, 
but accumulates in the vessels of the brain. Subsequent local laser irradiation causes photoexcitation 
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of the dye, intensive generation of highly toxic singlet oxygen, oxidative damage to the 
endothelium and basement membrane, platelet aggregation and microvessel occlusion, which leads 
to ischemic damage and death of nearby neurons and glial cells. Five minutes after the introduction 
of the photosensitizer, the brain region near the sensorimotor cortex (2 mm lateral to the bregma) 
(Franklin and Paxinos 2008) was irradiated by a an LPM-532-50 laser (NPF Dilaz, Russia). The 
irradiation parameters were the following: wavelength of 532 nm, intensity of 0.2 W/cm2, beam 
diameter of 1 mm, and duration of 15 min. Control groups included sham-operated animals that 
were subjected to the same manipulations without the photosensitizer. The animals were 
decapitated under terminal anesthesia with the chloral hydrate (600 mg/kg, i.p.) 3, 7, 14 or 21 days 
after the PTS. 
 
2.2 Immunofluorescence staining and image analysis 
 
At 3, 4, 7, 14, and 21 days after PTS mice were deeply anesthetized with chloral hydrate and 
perfused transcardially with 10% formalin solution in PBS. After extraction, the brains were post-
fixed in formalin overnight, then placed in 20% sucrose in PBS for 48 h at +4oC. Using a Leica VT 
1000 S vibratome (Germany) 20 μm thick frontal sections were obtained (starting with +2 mm and 
ending with -4 mm from bregma), which were frozen in 2-methylbutane and stored at -80 ° C.  
Antibody staining protocol was used as previously described (Demyanenko et al., 2018). Briefly, 
slices were washed in PBS, blocked in 5% bovine serum albumin (BSA, A7906) with 0.3% 
TritonX-100 in PBS for 1 h at room temperature and incubated with primary antibodies at 4°С 
overnight. Then, the slices were washed in PBS and incubated for 1 h in secondary antibodies. The 
following dilutions were used: rabbit Anti-Sirt1 (AV32386, Sigma), Anti-Sirt2 (S8447, Sigma), 
Anti-Sirt6 (S4322, Sigma) antibodies - 1:250; mouse Anti-Synaptophysin (S5768, Sigma), Anti-
GAP43 (NBP2-50052, Novus Biologicals), Anti-acetylated α-tubulin (T7451, Sigma), Anti-
Neuron-Specific Enolase (NSE, SAB4200571, Sigma) Anti-NeuN (TA809952, Thermo Fisher 
Scientific) and Gfap (SAB4200571, Sigma) antibodies - 1:500; secondary anti-Rabbit CF488A 
(SAB4600045) and anti-mouse CF555 (SAB4600302) antibodies - 1:1000. After incubation, the 
sections were washed three times for 5 minutes in PBS and incubated for 1 hour with secondary 
Anti-Rabbit CF488A (SAB4600045, Sigma) and Anti-mouse CF555 (SAB4600302, Sigma) 
antibodies in a 1: 1000 dilution. Control coverslips without primary antibody staining were also 
included. After washing in PBS, sections were mounted on glass in 60% glycerol in PBS. Imaging 
was performed with a color CCD camera 5 MP (Jenoptik, FRG) attached to an Eclipse FN1 
fluorescent microscope (Nikon, Japan). Three representative fields from each brain region per 
animal were digitally captured using an excitation wavelength of 490 nm and an emission 
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wavelength of 525 nm, and an excitation wavelength of 510 nm and an emission wavelength of 
565 nm (Nikon, Japan). 
Quantitative assessment of fluorescence of experimental and control preparations was 
carried out using 10–15 images acquired with the same camera settings as described previously 
(Demyanenko et al., 2020). Briefly, the corrected total cell fluorescence (CTCF) was calculated for 
estimation of the fluorescence (CTCF = Integrated Density – (Area of selected cell × Mean 
fluorescence of background readings)) (McCloy et al., 2014), analyzed at least 100 cells. To 
determine the localization of the protein in a cell CTCF was estimated in the regions of cytoplasm 
and nucleus. Threshold values were selected once and remained constant when processing all 
photos. Relative changes ΔI in fluorescence were calculated in comparison with the control group 
as ΔI = (Iex - Ic) / Ic, where Iex is the average value of the fluorescence intensity in the studied 
areas of the brain and Ic is the average value of the fluorescence intensity in the control samples. 
Data are presented as mean ΔI ± S.E.M.  
The co-localization of sirtuins with synaptophysin, GAP43, acetylated α-tubulin, the neuron 
markers (NSE or NeuN), the astrocytes marker (GFAP) and the nuclear marker Hoecsht33342 (10 
μg/ml; blue signal) was evaluated using the Image J program (http://rsb.info.nih.gov/ij/) with the 
JACoP plugin (Bolte and Cordelières, 2006). The Manders coefficient M1, which reflects the 
fraction of pixels with a red signal (synaptophysin, acetylated tubulin, cell type and nuclear marker 
or TUNEL staining) containing a green signal (proteins of interest) relative to the total signal from 
the red channel (Manders et al., 1992), was calculated for the RGB images (1280×960 pixels).  
No preliminary graphic editing was carried out to exclude distortion of the fluorescence 
intensity values. The regions of interest were blindly selected and analyzed. The analysis was 
performed on 3 images for each of 6-8 animals in the group. The values obtained were expressed as 
mean ± S.E.M. 
 
2.3 Sample processing 
 
Cortical tissue sampling and preparation of protein extracts were done as described 
previously (Demyanenko et al., 2018). Briefly, mice under chloral hydrate anesthesia were 
transcardially perfused with saline at 3, 7, 14, and 21 days after PTS. After the decapitation, the 
brain was isolated on ice; the cortex was separated; the damaged brain tissue was isolated by a 
circular knife 4 mm in diameter; and then a ring of undamaged tissue adjacent to the irradiated area 
and similar region in the contralateral hemisphere were cut using a knife with a diameter of 8 mm. 
The infarct and undamaged regions of ischemic ipsilateral hemisphere in PTS mice model were 
determine as described earlier (Demyanenko et al., 2018). The samples were homogenized on ice in 
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Lysis Buffer from the CelLytic™ NuCLEAR™ Extraction Kit (NXTRACT, Sigma), which was 
supplemented by a mixture of inhibitors of proteases and phosphatases that are necessary for 
preservation of proteins and their phosphorylated forms and by benzonase nuclease that destroys 
nucleic acids. After the homogenization, the samples were centrifuged for 5 min at 10 000–11 000 g 
at 4°С using a Mikro 220R centrifuge (Hettich, Germany). Then, a supernatant that contained 
cytoplasmic proteins was collected and the nuclear proteins were extracted from the pellet that 
contained cell debris and nuclei using a Nuclear Extraction Buffer from the NXTRACT kit. For 
this, the pellet was resuspended and incubated for 15 min with this buffer. After that, lysate was 
centrifuged for 10 min at 20 000–21 000 g at 4°С using the same centrifuge. The obtained 
supernatant that contains nuclear proteins and the cytoplasmic fraction obtained earlier were frozen 
in liquid nitrogen and stored at –80°С.  
 
2.4 Western blotting 
 
Bradford Reagent (В6916, Sigma) was used to determine protein content in the protein 
extracts according to the manufacturer’s recommendations for a Hitachi U-5100 spectrophotometer 
(Japan). Samples with 10–20 µg of protein in 15 µL were subjected to electrophoretic separation by 
Laemmli’s method in polyacrylamide gel (10–12.5%) in the presence of sodium dodecyl sulfate 
using Mini-PROTEAN Tetra cell (Bio-Rad). For quantitative estimation of the proteins under 
study, ColorBurst Electrophoresis Marker (C1992) was used. After the separation, the proteins were 
electrophoretically transferred to a PVDF membrane (162-0177, Bio-Rad). After the transfer, the 
protein membrane was washed in PBS and incubated for 1 h in a blocking buffer (TBS 1% Casein 
Blocker, 161-0782, Bio-Rad). After washing in PBS, the membrane was incubated overnight at 4 ° 
C with primary antibodies. The following dilutions of rabbit antibodies were used: 1:250 for Anti-
Sirt1 (AV32386, Sigma), Anti-Sirt2 (S8447, Sigma), Anti-Sirt6 (S4322, Sigma), γ-Tubulin 
(SAB4503045, Sigma) and 1:1000 for mouse antibodies against β-actin (A5441). After the 
incubation, the membrane was washed in a Tris buffer (ТТВS, 10 mM Tris buffered saline pH 8, 
0,1% Tween-20) and incubated with secondary antibodies anti-rabbit IgG-peroxidase at the dilution 
of 1:1000 (А6154) and peroxidase-labelled anti-mouse antibody (NIF825, Amersham) for 1 h at 
room temperature. Protein detection was performed using Сlarity Western ECL Substrate solutions 
(Bio-Rad). To analyze chemiluminescence, a Fusion SL system (Vilber Lourmat, France) and 
Vision Capt program were used.  
 
2.5 TUNEL assay 
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The “In Situ Cell Death Detection Kit, TMR red” (#12156792910, Roche) was used for 
detection and quantification of apoptotic cell death and for determination of co-localization of 
apoptotic cells (red signal) with cells labeled with antibodies for target proteins studied (green 
signals) as described previously (Demyanenko et al., 2020). The sections were first incubated with 
the primary antibody to the target protein as described above, washed and treated with reagents 
from the Cell detection kit as recommended by the manufacturer and incubated 1 h with the 
secondary antibody Anti-Rabbit CF488A (SAB4600045; 1:1000) and Hoechst 33342 (10 μg/ml; 
blue signal) at 370С. The apoptotic index (AI) was calculated for Tunel-positive cells in the 
penumbra, the contralateral hemisphere and in the cortex of sham-operated animals around the 
entire perimeter of the micropreparation at a 10x magnification according to the formula:  
AI = (number of TUNEL − positive cells/total number of cells stained by Hoechst 
33342) × 100 %. 
Additionally, the co-localization of the studied proteins (green signal) with the apoptosis 
marker (red signal) was evaluated using the Image J program (http://rsb.info.nih.gov/ij/) with the 
JACoP plugin. The Manders coefficient M1, which reflects the fraction of pixels with both red and 
green fluorescence in relation to the total signal from the red channel, was calculated for the RGB 
images (640×480). No preliminary graphic editing was carried out to exclude distortion of the 
fluorescence intensity values. The regions of interests were blindly selected and analyzed. The 
analysis was performed on 3 images for each of 5-7 animals in the group. The values obtained were 
expressed as mean ± S.E.M. 
 
 
2.6 Statistical analysis  
 
The data obtained are presented as mean ± S.E.M.; no less than three fields of view have 
been analyzed for each region of the brain (6 to 8 mice were studied). One-way analysis of variance 
(ANOVA) was used. Values of p < 0.05 were considered significant. 
 
 
3 Results  
 
 
3.1 Change in the expression and localization of SIRT1 in neurons and astrocytes of the cerebral 
cortex of mice during the recovery period after a PTS 
 
 SIRT1 is the most studied sirtuin, its brain level is higher than in other organs (Michishita et 
al., 2005). SIRT1 is a nuclear protein, but the presence of two nuclear export signals (NES) and two 
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nuclear localization signals (NLS) allows SIRT1 to move from the nucleus to the cytoplasm and 
vice versa (Tanno et al, 2007). 
 
  
Fig. 1 Expression and localization of SIRT1 in mouse cortex cells. (a) Double immunofluorescence 
staining with antibodies against SIRT1 (green), neuron markers NeuN and NSE (red) and Hoechst 
33342 (blue) showing the cortex of sham-operated mice and the damaged hemisphere at 7 and 14 
days after PTS. The scale bar is 100 μm. (b) The immunofluorescence of SIRT1 in the cortex at 
higher magnification (60x). The scale bar is 30 μm. (c) Percentage of changes in the fluorescence 
intensity of SIRT1-positive cells in the damaged (IL) and contralateral (CL) hemispheres at 
different time points after PTS relative to sham-operated animals in % (ΔIso). (d, e) Average values 
of the co-localization coefficient M1, that reflects the fraction of pixels with a red signal (NSE or 
GFAP) containing also green signal (SIRT1), relative to the total signal from the red channel. (f) 
Average values of the co-localization coefficient M1, that reflects the fraction of pixels with a blue 
signal (Hoechst 33342, nuclear marker) containing the green signal (SIRT1), relative to the total 
signal from the blue channel. (g) Western blot membranes showing SIRT1 in the nuclear and 
cytoplasmic fractions of the tissue of the cortex of sham-operated animals at 3-21 days after the 
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PTS in the damaged (IL) and the contralateral (CL) hemispheres. (ANOVA, n = 5-8; * p <0.05 
relative to sham-operated animals) 
 
 Our results showed that SIRT1 was present both in the nuclei and in the cytoplasm of 
neurons and astrocytes in the cortex of mice (Fig. 1a,b). IF analysis revealed a significant  increase 
in the total SIRT1 immunoreactivity in the cortex of the ischemic ipsilateral hemisphere (Fig. 1a,c) 
compared to the control at 7 and 14 days after the PTS. Also we observe a significant rise in the co-
localization of SIRT1 with neuron and astrocyte markers was observed (Fig. 1d,e). SIRT1 
translocation to the cytoplasm and an increase of the relative abundance of cells that contained the 
protein only in the cytoplasm was observed for the neurons (Fig. 1b). The co-localization 
coefficient of SIRT1 and the Hoechst nuclear marker levels decreases by 54 and 39% 7 and 14 days 
after the PTS, respectively (Fig. 1f). The results of the Western blot analysis also indicated an 
increase of SIRT1 level in the cytoplasmic fraction and a decrease of protein level in the nuclear 
fraction at 7 and 14 days after the PTS (Fig. 1g). 
 
3.2 SIRT1 expression is not associated with apoptosis 
 
 The nuclear form of SIRT1 is known to suppress cell apoptosis caused by oxidative stress 
(Tanno et al., 2007), whereas the cytoplasmic localization of SIRT1 enhances cell apoptosis (Jin et 
al., 2007). After PTS only in penumbra cells near the infarct nucleus the apoptosis was observed. In 
penumbra, SIRT1 had a nuclear-cytoplasmic localization (Fig. 2a). We did not observe the co-
localization of SIRT1 with apoptotically altered penumbra cells at 3 and 7 days after the PTS in the 
cerebral cortex of mice (Fig. 2a), although apoptosis of penumbra cells increased compared to 
sham-operated animals (Fig. 2b). 
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Fig.2 SIRT1 co-localization with apoptotic cells and plasticity-related proteins. (a) Typical 
fluorescence image of the penumbra at 7 days after PTS, sections were stained using the TUNEL 
method (red) to visualize apoptotic nuclei, SIRT1 (green) and the Hoechst 33342 cell nucleus 
marker (blue). The scale bar is 100 μm. (b) Changes in apoptotic index (AI, %) in sham-operated 
animals (SO) and in penumbra at 3-21 days after PTS. (c, d) Percentage of changes in the 
fluorescence intensity of SYN (c) and GAP43 (d) in the damaged (IL) and contralateral (CL) 
hemispheres at different time points after the PTS relative to sham-operated animals (ΔIso). (e, f) 
Double staining with antibodies against SIRT1 (green), GAP43 (red) or synaptophysin (red) of the 
damaged mouse cortex 14 days after PTS. The scale bar is 100 μm. (g, h) Average values of the co-
localization coefficient M1, that reflects the fraction of pixels with a red signal GAP43 (g) or 
synaptophysin (h) containing a green signal (SIRT1), relative to the total signal from the red 
channel. (ANOVA, n = 5-8 * p <0.05 relative to sham-operated animals) 
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3.3 SIRT1 is associated with synaptic plasticity proteins 
 
 Synaptophysin (SYN) and growth-associated protein 43 (GAP-43) are two important 
synapse-associated proteins. The presynaptic marker SYN is a synaptic vesicle protein that is 
involved in the regulation of synaptic transmission efficiency (Wheeler et al., 2002). 
 On the third day after PTS, we observe, a 36% decrease in the SYN IF level in cortical cells 
was observed, but on day 7, the SYN expression in the intact cerebral cortex of the injuried 
hemisphere was 31% higher than in sham-operated animals and remained high up to 14 days. On 
day 21, the protein level did not differ from the control level (Fig. 2с). 
 GAP-43 is a protein associated with the growth of neurites during the development and 
regeneration of the nervous system and during the recovery period following ischemia (Benowitz 
and Routtenberg, 1997; Carmichael et al., 2005). GAP-43 is also present on the postsynaptic 
membrane (Stroemer et al., 1993) and, in addition to lengthening cell projections, is involved in a 
more complex setup of intercellular networks necessary for proper tissue regeneration (Gorup et al., 
2015). 
 In the cells of the cortex of the intact region of the ipsilateral hemisphere of the mouse brain, 
the GAP-43 IF level was significantly 48% increased on the 7th day and remains high up to 21 days 
after PTS compared to sham- operated animals (Fig. 2c) 
 An increase of GAP-43 level in the brain after a stroke can be either a result of regeneration 
processes or a result of protein release from damaged axons at the early stages after PTS. The 
increase of the cytoplasmic SIRT1 levels in neurons at 7 and 14 days after PTS was correlated with 
the expression of SYN and GAP-43 in this period after PTS. In neurons ischemic hemisphere of 
mice, the increase of co-localization SIRT1 and SYN (Fig.2 c,e), as well as SIRT1 and GAP43 
(Fig.2 d,f), were observed at 7 and 14 days after PTS. 
 
3.4 Changes in the expression and localization of SIRT2 in neurons and astrocytes of the cerebral 
cortex of mice during the recovery period after IPT 
 
In the central nervous system, SIRT2 is the only sirtuin isoform with a mainly cytoplasmic 
localization, but it can temporarily move to the nucleus depending on the cell cycle (Vaquero et al., 
2006). Our IF and WB analysis also indicate exclusively cytoplasmic localization of the enzyme in 





Fig. 3 Expression and localization of SIRT2 in mouse cortex cells. (a) Double immunofluorescence 
staining with antibodies against SIRT2 (green), the neuronal marker NSE and the astrocytes marker 
GFAP (red) and Hoechst 33342 (blue) of the cortex of sham-operated mice, damaged and 
contralateral hemispheres at 3 days after PTS. The scale bar is 100 μm. (b) Percentage changes in 
the fluorescence intensity of SIRT2-positive cells in the damaged (IL) and contralateral (CL) 
hemispheres at different times points after PTS relative to sham-operated animals in % (ΔIso). (c) 
Average values of the co-localization coefficient M1, reflecting the fraction of pixels with a red 
signal (NSE) containing a green signal (SIRT2), relative to the total signal from the red channel. (d) 
Western blot membranes presenting SIRT2 in the cytoplasmic fractions of the tissue of the cortex of 
sham-operated animals and 3-21 days after the PTS in the damaged (IL) or contralateral (CL) 
hemispheres. (e) Double staining with antibodies against SIRT2 (green) and acetylated α-tubulin 
(red) showing the damaged cortex of mice 3 days after PTS. The scale bar is 50 μm (f) Average 
values of the co-localization coefficient M1, reflecting the fraction of pixels with a red signal (ac-α-
tubulin) containing the green signal (SIRT2), relative to the total signal from the red channel. 
(ANOVA, n = 5-8 * p <0.05 relative to sham-operated animals) 
 
 At the early stages after occlusion of the middle cerebral artery (MCAO), an increase of the 
nuclear form of SIRT2 level was detected in mice and in the penumbra of stroke survivors (Xie et 
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al., 2017). According to our research, at the early recovery period after PTS, there is no 
translocation of SIRT2 between the nucleus and the cytoplasm in neurons (Fig. 3a). However, we 
also noted an increase of protein immunoreactivity in neurons of the ipsilateral cortex, which was 
consistent in the observations in human patients in the early recovery period on the first day after a 
stroke (Xie et al., 2017), and, importantly, in the contralateral hemispheres of the mouse brains 3 
days after PTS. This is indicated by both the IF analysis data (Fig. 3 a,b,c) and the results of a WB 
analysis (Fig. 3d). 
 α -tubulin is known to be the substrate of SIRT2 in the cytoplasm (North et al., 2003). 
According to immunofluorescence analysis, an SIRT2 expression increase was associated with an 
increase of acetylated α-tubulin (Ac-α-tub) level. The colocalization of SIRT2 and Ac-α-tub in the 
cortex of the damaged and contralateral hemispheres of the mouse brain increased 3 days after PTS 
(Fig. 3 e, f). No SIRT2 IF signal was detected in apoptotic cells. 
 
3.5 Changes in the expression and localization of SIRT6 in neurons and astrocytes of the cerebral 
cortex of mice during the recovery period after PTS. SIRT6 binding to synapse-associated proteins 
 
Little is known about SIRT6. In our study, we observed the expression of SIRT6 in neurons and 
astrocytes of the cerebral cortex of sham-operated animals, both in the nuclei and in the cytoplasm 
of cells (Fig. 4a). Both the expression and intracellular localization of SIRT6 did not significantly 
change after PTS. However, at 14 days after PTS, we observe an increase in SIRT6 co-localization 
with GAP43 in neurons of the cortex of the ischemic hemisphere of the mouse brain was observed 
(Fig. 4 b,c). We did not observe co-localization of SIRT6 with apoptotic cells, similarly to SIRT1 
and SIRT2. This indicates that these histone acetyltransferases are not involved in the PTS-induced 




Fig. 4 Expression and localization of SIRT6 in mouse cortex cells. (a) Double immunofluorescence 
staining with antibodies against SIRT6 (green), the neuronal marker NSE, the astrocytes marker 
GFAP (red) and Hoechst 33342 (blue) in the cortex of sham-operated mice. The scale bar is 100 
μm. Double staining with antibodies against SIRT2 (green) and acetylated α-tubulin (red) of the 
damaged cortex of mice 3 days after PTS. The scale bar is 100 μm. (b) Double staining with 
antibodies against SIRT6 (green) and GAP43 (red) of the damaged cortex of mice 14 days after 
PTS. The scale bar is 100 μm. (c) Average values of the co-localization coefficient M1, that reflects 
the fraction of pixels with a red signal (GAP43) containing the green signal (SIRT6), relative to the 






There is no doubt that sirtuins are modulators of many biological processes under both normal and 
pathological conditions of the body and, in particular, under ischemic stroke. 
SIRT1 has shown neuroprotective effects in numerous studies on models of ischemic stroke, brain 
injury, and neurodegenerative diseases (She et al., 2017; Ng et al., 2015). In SIRT1 knockout mice, 
an increase in infarct size has been observed after MCAO (Hernandez-Jimenez et al., 2013), while 
mice overexpressing  SIRT1 were more resistant to ischemia (Hattori et al., 2015). SIRT1 activators 
reduce the size of infarct (Li et al., 2012). 
An increase of SIRT1 expression level in the penumbra of the cerebral cortex of mice was shown 
up to 7 days after MCAO (Hernández-Jiménez et al. 2013). In the PTS model, an increase of SIRT1 
expression level was observed up to 14 days in both neurons and astrocytes of intact areas of the 
cerebral cortex of mice. 
Since SIRT1 deacetylates histones and various transcription factors (She et al., 2017; Khoury et al., 
2018) and may have chaperone-like activity (Pfister et al., 2008), its subcellular localization should 
affect its function. It is known that subcellular localization of SIRT1 can change during brain 
development and in response to physiological and pathological stimuli (Tanno et al., 2007; Hisahara 
et al., 2008). SIRT1 localized in the nucleus has been shown to prevent apoptosis by deacetylation 
of p53 (Luo et al., 2001), FOXO (Brunet et al., 2004) and Ku70 (Cohen et al. Al., 2004). Not much 
is known about the functions of the cytoplasmic form of SIRT1. SIRT1 localized in the cytoplasm 
has been shown to enhance caspase-dependent cell apoptosis (Jin et al., 2007). However, our results 
show that SIRT1 translocation into the cytoplasm was not associated with apoptosis of cells 
adjacent to the damage nucleus, 7 days after focal ischemia caused by photothrombosis of the 
cerebral cortex,. In contrast, cytoplasmic SIRT1 was associated with synaptic plasticity proteins 
SYN and GAP43. 
Ischemic stroke is the main cause of disability worldwide after which surviving neurons in the peri-
infarction region form new connections through the growth of neurites and synaptogenesis as part 
of the recovery process [Ueno et al., 2012]. Synaptophysin (SYN) is a marker of synaptic contacts 
and synaptogenesis (Fletcher T.L. et al., 1991). This is a protein of the membranes of synaptic 
vesicles in the presynaptic terminals of neurons, and it is involved in the regulation of the formation 
of vesicles and their exocytosis. SYN levels are used as a marker for synaptic vesicle counts and 
synaptogenesis, as well as a marker for synaptic transmission efficiency (Wheeler et al., 2002; 
Gordon 2011 et al., 2011). SYN expression reflects the plasticity of the nervous system during 
ischemic damage, and the restored expression of synaptophysin indicates recovery from stroke 
(Zhang et al. 2017; Fang et al., 2010). Most likely with the growth of apoptosis level of the 
penumbra cells at 3 and 7 days after the PTS, protein expression and synaptic processes in the areas 
adjacent to the damage nucleus are slowed down; therefore, we observe a decrease in the SYN level 
in the relatively intact cortex of the ipsilateral hemisphere after the PTS. However, already at the 
7th day, SYN expression level is restored and becomes even higher than in animals without PTS. 
Coinciding with the increase of SYN level the level of cytoplasmic SIRT1 increases at 7 and 14 
days after the PTS. 
 
At the same time, the co-localization of SIRT1 with another marker of regeneration GAP43 -
increases. In rodents, after transient middle cerebral artery occlusion (tMCAo), GAP43 is present at 
an early stage in the site of ischemic lesion, followed by expression in the penumbra (Li et al., 
1998), suggesting an early activation of GAP43 to preserve and regenerate tissues. With constant 
MCAO, where the tissue is more severely and irreversibly damaged, GAP-43 is absent in the core 
of the infarct but its expression increases in the penumbra, reaching a maximum on day 7 (Miyake 
et al., 2002). The PTS model is characterized by rapid vascular damage and cell death in the infarct, 
which makes the formation of a wide penumbra impossible (Lee et al., 2007; Uzdensky et al., 
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2017). This might be the reason we are observing an increase in the level of GAP43 in the relatively 
intact region of the ipsilateral hemisphere starting from the 7th day after the PTS. The delayed 
increase in GAP43 after PTS may reflect the time required for the spreading of the neuronal 
damage to larger sections of the peri-infarction space and the time delay before the death of neurons 
expressing GAP43 with the release of protein into the extracellular space, as well as the time 
required for the complex setup of intracellular and intercellular networks necessary for proper tissue 
regeneration. In our study, the expression of GAP43 remains high until 21 days after PTS with a 
maximum at 7 days. In this case, a co-localization of the cytoplasmic form of SIRT1 and GAP43 is 
observed on the 7th and 14th day after ischemia, which indicates the participation of SIRT1 in the 
regulation of tissue repair and brain function after a stroke. Moreover, the cytoplasmic localization 
may be an important determinant of the effect of SIRT1 on neuroplasticity. It was previously shown 
that resveratrol stimulated neurite growth and in vitro nerve cell synaptogenesis (Tang et al., 2017). 
It was shown that cytoplasmic SIRT1 increased neurite growth caused by nerve growth factor 
(NGF), while SIRT1 or SIRT1-siRNA inhibitors significantly inhibited it (Sugino et al., 2010). 
 
SIRT2 is the closest homolog of SIRT1. It is been previously reported that in the ischemic brain, 
SIRT2 is activated in myelin-rich areas of the brain, mainly in oligodendrocytes, while its 
expression has not been detected in astrocytes, microglia, or neurons (Krey et al., 2015). In our 
study, SIRT2 is found in the cytoplasm of neurons, but not in the astrocytes of the mouse cortex, 
which is consistent with the data obtained by Maxwell et al. in 2011. 
In a recent study, Xie et al. (2017) showed that inhibition of SIRT2 in the brain has a 
neuroprotective effect in the tMCAO mouse model. Moreover, the authors report a high expression 
of SIRT2 in the cytoplasm of neurons, but not in microglia or astrocytes. In response to ischemia, 
SIRT2 translocates to the nuclei of the neurons (Xie et al., 2017). In studies using a differentiated 
PC12 cell line, Nie et al. (2014) showed that in response to oxidative stress, SIRT2 levels increase 
leading to apoptosis caused by oxidative stress. Moreover, overexpression of the cytoplasmic form 
of SIRT2 in cerebellar granule neurons or HT22 cells can cause apoptosis (Pfister et al., 2008). In 
our study, we observed an increase in the level of cytoplasmic SIRT2 in the neurons of the cortex of 
the damaged and, more interestingly, intact cerebral hemispheres of mice at 3 days after PTS. 
However, this increase in SIRT2 levels in the cytoplasm of neurons was not associated with 
apoptosis of penumbra cells at these times. It is known that not only Sirt2 mRNA, but also Sirt2 
protein isoforms respond differently to ischemia (Krey et al., 2015). Thus, the expression of the 
main cytoplasmic isoform (SIRTv2) decreases after MCAO compared to sham-operated mice, and 
v1 isoform (SIRTv1) is actively expressed both in the ischemic (ipsilateral) and non-ischemic 
(contralateral) hemispheres of the brain compared to sham-operated animals, that we also observe 
on the third day after PTS. Despite the fact that most studies indicate the pathological role of SIRT2 
in brain ischemia (She et al., 2017; Xie et al., 2017), in our opinion, the function of SIRT2 in the 
ischemic brain is much more complicated than simply pathological or neuroprotective and depends 
on the cellular and intracellular localization of different isoforms of the enzyme, its phosphorylation 
level and the type of substrate. 
In the cytoplasm, both the NAD + -dependent SIRT2 and the NAD + -independent HDAC6 class II 
are known to play an important role in the regulation of microtubule dynamics by deacetylation of 
α-tubulin with lysine 40 (North et al., 2003). SIRT2 and HDAC6 are likely to deacetylate α-tubulin 
both in combination with each other (Nahhas et al., 2007) and separately (North et al., 2003). 
Acetylation of α-Tub increases microtubule stability, improves the interaction between α-tubulin 
and motor proteins, which facilitates microtubule-based transport (Magiera and Janke 2014). The 
microtubule-based transport is necessary for numerous processes occurring in neurons, such as 
neurotransmission, axon germination and regeneration, synaptogenesis, etc. (Liu et al., 2012). 
Earlier, we showed that PTS causes a significant decrease of the level of the acetylated form of α-
tubulin in the cerebral cortex of mice up to 7 days after injury (Demyanenko et al., 2019). In this 
case, the administration of the selective HDAC6 inhibitor tubastatin A restored the level of Ac-α-
Tub to control values ADemyanenko et al., 2019; Wang et al., 2016). Our study shows the high co-
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localization of SIRT2 and the acetylated tubulin. This is probably due to the fact that SIRT2 
involvement is limited by perinuclear microtubules, and HDAC6 activation leads to general 
hypоacetylation of the microtubule network throughout the cell (Skoge and Ziegler, 2016). 
Perinuclear microtubules surround the nucleus, linking it to the periphery of the cell. In neurons, 
hypoacetylated perinuclear microtubules are involved in nuclear translocation of proteins or 
mitochondria (Stiess and Bradke, 2011). This specificity of SIRT2 is probably achieved due to the 
smaller protein size compared to HDAC6 or it could have easier access through transient 
microtubule lattice openings between protofilaments (Skoge and Ziegler, 2016). In addition, it was 
shown that only the specific isoform SIRT2, SIRT2.3, deacetylates α-tubulin in the brain and spinal 
cord of old mice (Maxwell et al., 2011). Thus, a decrease in α-tubulin acetylation after stroke is 
likely to be associated with activity HDAC6, rather than with SIRT2 activity. 
 
SIRT6 is the least studied non-mitochondrial sirtuin. SIRT6 immunoreactivity was detected both in 
neurons and in astrocytes (Favero et al., 2014), that correlates with our data obtained. SIRT6 is 
believed to act on acetylated lysine residues such as H3K9ac and H3K56ac, which causes 
repression of genes associated with aging (Tennen et al., 2011). However, the role of SIRT6 in 
ischemia is largely unclear and controversial. On the one hand, SIRT6 can protect the brain from 
ischemic reperfusion (I / R) damage by suppressing oxidative stress by activating NRF2 (Zhang et 
al., 2017). On the other hand, overexpression of SIRT6 in cultured neurons led to decreased 
viability and increased cell necrosis under oxidative stress caused by a lack of oxygen and glucose 
(Shao et al., 2016). We did not observe protein IF signal in apoptotic penumbra cells. This is likely 
due to the ability of SIRT6 to repair DNA (Tennen et al., 2011; Mao et al., 2011). 
 
It was previously shown that SIRT6 is contained in a significant amount in the synaptosomal 
fractions of mouse cortex and hippocampal neurons (Cardinale et al., 2015). However, we did not 
find a co-localization of SIRT6 with synaptophysin marker of presynaptic vesicles after PTS. 
However, the protein was co-expressed with a marker of axonogenesis and postsynaptic membranes 
- GAP43 protein on the 14th day after ischemia. Whether this is due to the fact that SIRT6 can be a 
part of the multi-protein complex of the postsynaptic membrane (Cardinale et al., 2015) or that the 
protein is involved in the regulation of neurite growth during the recovery of brain tissue after a 




There is no doubt that sirtuins are involved in the regulation of tissue repair processes and brain 
functions after a stroke. However, in light of the present and previous results, it cannot be said 
whether the effect of sirtuins on cell survival and repair following stroke is unequivocally negative 
or positive. Their functions seem very complex and they differ depending on the cell type, 
intracellular localization, the specificity of the different isoforms of sirtuins to different substrates, 
and the nature of post-translational modifications of enzymes. Thus, further experimental studies in 
vivo and in vitro of the cellular and intracellular redistribution of sirtuins will give a better 
understanding of the molecular mechanisms underlying the restoration of the functions of neurons 
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